NCAM1 and vitiligo: To test this speculation, skin resident immune cells were isolated from cultured vitiligo skin explants [40], [41] and analysed for cellular compositions and activation status using antibodies against CD3 (a pan T cell marker), CD56 (a specific natural killer cell marker) and granzyme B (a cytotoxicity marker for NK cells).